Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Hodgkin disease--pathogenesis and therapy]

J Wolf1, V Diehl

  • 1Medizinische Klinik I, Universität zu Köln.

Therapeutische Umschau. Revue Therapeutique
|February 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Autologous hematopoietic cell transplantation for high-risk ALL.

Bone marrow transplantation·2010
Same author

Heritabilities and genetic correlations for litter size and semen traits in Czech Large White and Landrace pigs.

Journal of animal science·2010
Same author

Economic weights of production and functional traits for Holstein-Friesian cattle in Hungary.

Journal of animal breeding and genetics = Zeitschrift fur Tierzuchtung und Zuchtungsbiologie·2010
Same author

Basal cell epithelioma of the forearm.

Archives of dermatology and syphilology·2010
Same author

A case for diagnosis (lupus erythematosus? chloasma?).

Archives of dermatology and syphilology·2010
Same author

Pityriasis rubra pilaris.

Archives of dermatology and syphilology·2010
Same journal

[Multimodal Cardiac Imaging: New Developments for Clinical Practice].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

[Coronary angiography: From cardiac catheterization to advanced interventional cardiovascular imaging].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

[Athlete's heart: role of cardiac imaging in the prevention of sudden cardiac death].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

[Multimodal imaging in cardiac amyloidosis and cardiac sarcoidosis].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

[Inflammatory Heart Disease: The Role of Multimodality Cardiac Imaging in Myocarditis and Pericarditis].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

State-of-the-Art Cardiac Imaging

Therapeutische Umschau. Revue therapeutique·2026
See all related articles

Hodgkin's lymphoma originates from B-cells and involves an atypical immune response. Current treatments focus on disease stage, offering a high cure rate for most patients.

Area of Science:

  • Hematopoietic neoplasia
  • Immunology
  • Oncology

Context:

  • Hodgkin's lymphoma presents as a malignancy with an atypical immune response, characterized by malignant Hodgkin-Reed Sternberg (H-RS) cells within a reactive microenvironment.
  • The immune response, particularly T-cells, appears pronounced but inefficient against undefined antigens on H-RS cells.
  • The role of Epstein-Barr virus (EBV) in approximately 50% of cases requires further elucidation.

Purpose:

  • To investigate the cellular origin of Hodgkin-Reed Sternberg (H-RS) cells in Hodgkin's disease.
  • To demonstrate the monoclonal B-cell origin of H-RS cells using advanced molecular techniques.
  • To provide insights into the pathogenesis of Hodgkin's lymphoma.

Summary:

  • Single-cell PCR analysis of micromanipulated H-RS cells confirmed a monoclonal B-cell origin in several Hodgkin's disease cases.

Related Experiment Videos

  • This finding supports the classification of Hodgkin's lymphoma as a hematopoietic neoplasia.
  • Therapeutic strategies are stage-dependent, not based on histological subtype, leading to high cure rates.

    • Impact:

    • Establishes the B-cell lineage of H-RS cells, crucial for understanding Hodgkin's lymphoma pathogenesis.
    • Highlights the importance of precise staging in treatment decisions for Hodgkin's lymphoma.
    • Confirms the efficacy of current treatment protocols, achieving high cure rates and exploring advanced therapies for relapsed cases.